These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25131905)

  • 1. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
    Nakahashi T; Arita T; Yamaji K; Inoue K; Yokota T; Hoshii Y; Fukunaga M; Nomura A; Watanabe H; Miura S; Isotani A; Soga Y; Ando K; Iwabuchi M; Yokoi H; Nosaka H; Yamagishi M; Nobuyoshi M
    Int J Cardiol; 2014 Oct; 176(3):753-9. PubMed ID: 25131905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses.
    Mori M; An Y; Katayama O; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Murata K; Yokota T; Ando K; Imada K
    Ann Hematol; 2015 Nov; 94(11):1885-90. PubMed ID: 26251157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Edema and Prognosis in Amyloidosis.
    Kotecha T; Martinez-Naharro A; Treibel TA; Francis R; Nordin S; Abdel-Gadir A; Knight DS; Zumbo G; Rosmini S; Maestrini V; Bulluck H; Rakhit RD; Wechalekar AD; Gilbertson J; Sheppard MN; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2018 Jun; 71(25):2919-2931. PubMed ID: 29929616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.
    Hu K; Liu D; Nordbeck P; Cikes M; Störk S; Kramer B; Gaudron PD; Schneider A; Knop S; Ertl G; Bijnens B; Weidemann F; Herrmann S
    Int J Cardiovasc Imaging; 2015 Oct; 31(7):1401-12. PubMed ID: 26179863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Standard Echocardiographic Parameters in Endomyocardial Biopsy Proven Cardiac Amyloidosis.
    Biočić S; Jurinjak SJ; Vincelj J; Barić D; Manojlović S; Brkljačić DD
    Coll Antropol; 2015 Jun; 39(2):441-5. PubMed ID: 26753463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
    Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
    Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac amyloidosis without increased left ventricular wall thickness.
    Lee GY; Kim K; Choi JO; Kim SJ; Kim JS; Choe YH; Grogan MA; Jeon ES
    Mayo Clin Proc; 2014 Jun; 89(6):781-9. PubMed ID: 24702732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
    Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.
    Singulane C; Sun D; Hu Z; Lee L; Sarswat N; Emami Neyestanak M; Patel AR; Lang RM; Addetia K
    Curr Probl Cardiol; 2024 Sep; 49(9):102729. PubMed ID: 38945183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
    Koyama J; Falk RH
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):333-42. PubMed ID: 20394893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
    Itzhaki Ben Zadok O; Vaturi M; Vaxman I; Iakobishvili Z; Rhurman-Shahar N; Kornowski R; Hamdan A
    PLoS One; 2021; 16(8):e0255487. PubMed ID: 34370783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac Amyloidosis.
    Bodez D; Guellich A; Kharoubi M; Covali-Noroc A; Tissot CM; Guendouz S; Hittinger L; Dubois-Randé JL; Lefaucheur JP; Planté-Bordeneuve V; Adnot S; Boyer L; Damy T
    Sleep; 2016 Jul; 39(7):1333-41. PubMed ID: 27091529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.
    Ng B; Connors LH; Davidoff R; Skinner M; Falk RH
    Arch Intern Med; 2005 Jun; 165(12):1425-9. PubMed ID: 15983293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.
    Cappelli F; Baldasseroni S; Bergesio F; Perlini S; Salinaro F; Padeletti L; Attanà P; Paoletti Perini A; Moggi Pignone A; Grifoni E; Fabbri A; Marchionni N; Gensini GF; Perfetto F
    Clin Cardiol; 2015 Feb; 38(2):69-75. PubMed ID: 25645201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.